|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Company Profile For Abnova (Taiwan) Corporation
10/19/2005 5:12:11 PM
Abnova Corporation provides scalable, high throughput protein expression and monoclonal antibody production via proprietary technologies, fully automated platforms, industrial-scale infrastructure and state-of-the-art SPF animal facility. Abnova leverages its expertise to advance four principal business activities: custom service, partnership, catalog, and licensing. It is concurrently developing the most comprehensive, antibody bio-tool catalog for the drug discovery and diagnostic industry by focusing on several key areas of human proteins: kinases, apoptosis, receptors, stem cell and plasma proteome. Abnova has two manufacturing sites totaling 44,000 sq ft in Taiwan with 130 employees, and a wholly owned subsidiary, Abnova GmbH, in Germany.
|
|
|
|
|
|
|
|
|
|
|